← FDA Drug Approvals (Drugs@FDA)
NARATRIPTAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2010-07-08
Drug application
- FDA Application #
ANDA091326- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NARATRIPTAN
- Generic name
- Naratriptan Hydrochloride
- Active ingredients
- NARATRIPTAN HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PADAGIS US
- First approval
- 2010-07-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown